Admission Hyperglycemia in Non-diabetics Predicts Mortality and Disease Severity in COVID-19: a Pooled Analysis and Meta-summary of Literature.
COVID-19
Diabetes
Hyperglycemia
Infectious disease
SARS-CoV-2
Journal
SN comprehensive clinical medicine
ISSN: 2523-8973
Titre abrégé: SN Compr Clin Med
Pays: Switzerland
ID NLM: 101740833
Informations de publication
Date de publication:
2020
2020
Historique:
accepted:
04
10
2020
pubmed:
20
10
2020
medline:
20
10
2020
entrez:
19
10
2020
Statut:
ppublish
Résumé
In the latter part of 2019, a cluster of unexplained pneumonia cases were reported in Wuhan, China. In less than a year, SARS-CoV-2 has infected over 27 million people and claimed more than 800,000 deaths worldwide. Diabetes is a highly prevalent chronic metabolic disease, and recent reports have suggested a possible existence of COVID-19 related new-onset diabetes. Hyperglycemia induces an inflammatory state in the body, which coupled with coronavirus associated immune response is a possible explanation for clinical worsening of patients. We present a summary and pooled analysis of available evidence to ascertain the relationship between hyperglycemia in undiagnosed diabetics and outcomes of COVID-19 disease. Our results showed that hyperglycemia in non-diabetics was associated with higher risk of severe/critical illness (OR 1.837 (95% CI 1.368-2.465,
Identifiants
pubmed: 33073173
doi: 10.1007/s42399-020-00575-8
pii: 575
pmc: PMC7550017
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2161-2166Informations de copyright
© Springer Nature Switzerland AG 2020.
Déclaration de conflit d'intérêts
Conflict of InterestThe authors declare that they have no conflict of interest.
Références
J Infect. 2020 Sep;81(3):e20-e23
pubmed: 32652167
J Clin Endocrinol Metab. 2000 Aug;85(8):2970-3
pubmed: 10946914
Diabetes Res Clin Pract. 2020 Oct;168:108381
pubmed: 32853687
Diabetes Care. 2020 Jul;43(7):1408-1415
pubmed: 32430456
Diabetes Res Clin Pract. 2020 Oct;168:108374
pubmed: 32805345
Am J Med Sci. 2016 Feb;351(2):201-11
pubmed: 26897277
J Diabetes Sci Technol. 2020 Jul;14(4):813-821
pubmed: 32389027
Emerg Infect Dis. 2020 Jan;26(1):166-168
pubmed: 31855530
J Am Coll Cardiol. 2009 Feb 3;53(5 Suppl):S9-13
pubmed: 19179217
BMJ Open Diabetes Res Care. 2020 Jun;8(1):
pubmed: 32503812
Diabetologia. 2020 Oct;63(10):2102-2111
pubmed: 32647915
Diabetes Res Clin Pract. 2020 Sep;167:108338
pubmed: 32712122
Diabetes Care. 2020 Oct;43(10):2345-2348
pubmed: 32788285
Acta Diabetol. 2010 Sep;47(3):193-9
pubmed: 19333547
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Diabetes Obes Metab. 2020 Oct;22(10):1897-1906
pubmed: 32469464
J Med Virol. 2021 Jan;93(1):409-415
pubmed: 32589756
J Med Virol. 2020 Jul;92(7):770-775
pubmed: 32293710
Front Endocrinol (Lausanne). 2020 Jul 10;11:525
pubmed: 32754119
Diabet Med. 2006 Jun;23(6):623-8
pubmed: 16759303
Diabetes Res Clin Pract. 2020 Jun;164:108185
pubmed: 32360710
Diabetes Care. 2005 Apr;28(4):810-5
pubmed: 15793178
Diabetes Obes Metab. 2020 Aug;22(8):1443-1454
pubmed: 32406594
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):395-403
pubmed: 32334395
BMJ. 2012 May 28;344:e3397
pubmed: 22645184